These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22362747)

  • 1. Investigating the entire course of telithromycin binding to Escherichia coli ribosomes.
    Kostopoulou ON; Petropoulos AD; Dinos GP; Choli-Papadopoulou T; Kalpaxis DL
    Nucleic Acids Res; 2012 Jun; 40(11):5078-87. PubMed ID: 22362747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
    Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding site of the bridged macrolides in the Escherichia coli ribosome.
    Xiong L; Korkhin Y; Mankin AS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis.
    Petropoulos AD; Kouvela EC; Dinos GP; Kalpaxis DL
    J Biol Chem; 2008 Feb; 283(8):4756-65. PubMed ID: 18079110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action.
    Dunkle JA; Xiong L; Mankin AS; Cate JH
    Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17152-7. PubMed ID: 20876128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.
    Tu D; Blaha G; Moore PB; Steitz TA
    Cell; 2005 Apr; 121(2):257-70. PubMed ID: 15851032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the mode of action of novel fluoroketolides, potent inhibitors of bacterial protein synthesis.
    Krokidis MG; Márquez V; Wilson DN; Kalpaxis DL; Dinos GP
    Antimicrob Agents Chemother; 2014; 58(1):472-80. PubMed ID: 24189263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA.
    Hansen LH; Mauvais P; Douthwaite S
    Mol Microbiol; 1999 Jan; 31(2):623-31. PubMed ID: 10027978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-distance rRNA base pair impacts the ability of macrolide antibiotics to kill bacteria.
    Svetlov MS; Cohen S; Alsuhebany N; Vázquez-Laslop N; Mankin AS
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):1971-1975. PubMed ID: 31932436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre.
    Xiong L; Shah S; Mauvais P; Mankin AS
    Mol Microbiol; 1999 Jan; 31(2):633-9. PubMed ID: 10027979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity.
    Kouvela EC; Kalpaxis DL; Wilson DN; Dinos GP
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1411-9. PubMed ID: 19164155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study.
    Nguyen HL; An PH; Thai NQ; Linh HQ; Li MS
    J Mol Graph Model; 2019 Sep; 91():80-90. PubMed ID: 31200217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA.
    Novotny GW; Jakobsen L; Andersen NM; Poehlsgaard J; Douthwaite S
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3677-83. PubMed ID: 15388419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial elements that maintain the interactions between the regulatory TnaC peptide and the ribosome exit tunnel responsible for Trp inhibition of ribosome function.
    Martínez AK; Shirole NH; Murakami S; Benedik MJ; Sachs MS; Cruz-Vera LR
    Nucleic Acids Res; 2012 Mar; 40(5):2247-57. PubMed ID: 22110039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
    Poulsen SM; Kofoed C; Vester B
    J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformations in solution and bound to bacterial ribosomes of ketolides, HMR 3647 (telithromycin) and RU 72366: a new class of highly potent antibacterials.
    Evrard-Todeschi N; Gharbi-Benarous J; Gaillet C; Verdier L; Bertho G; Lang C; Parent A; Girault JP
    Bioorg Med Chem; 2000 Jul; 8(7):1579-97. PubMed ID: 10976506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
    Douthwaite S; Hansen LH; Mauvais P
    Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 23S rRNA 2058A-->G alteration mediates ketolide resistance in combination with deletion in L22.
    Berisio R; Corti N; Pfister P; Yonath A; Böttger EC
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3816-23. PubMed ID: 16923950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-resolved binding of azithromycin to Escherichia coli ribosomes.
    Petropoulos AD; Kouvela EC; Starosta AL; Wilson DN; Dinos GP; Kalpaxis DL
    J Mol Biol; 2009 Jan; 385(4):1179-92. PubMed ID: 19071138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.